Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

CLL Cells within the Proliferation Centers of the Patient Lymph Nodes Are Enriched for Notch Signaling, Thus NOTCH a Viable Target for CLL Therapy

Shantaram S. Joshi, Matt Kilng, Furqan Mehdi, Mamta Shukla, Ashima Bhakri, Vipul Shukla, Nagendra K. Chaturvedi, Hamid Band, Javeed Iqbal

Blood (2023) 142 (Supplement 1): 6519.

https://doi.org/10.1182/blood-2023-190855

Published: 2023

Journal Articles

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL

Ashima Shukla, Karan Rai, Vipul Shukla, Nagendra K. Chaturvedi, R. Gregory Bociek, Samuel J. Pirruccello, Hamid Band, Runqing Lu, Shantaram S. Joshi

Blood (2016) 127 (19): 2310–2321.

https://doi.org/10.1182/blood-2015-09-669317

Published: 2016

Includes: Supplemental data

Journal Articles

Mirna-21 Targets Sprouty2 to Activate SYK Mediated BCR and MAPK-Erk Signaling in Chronic Lymphocytic Leukemia

Ashima Shukla, BSc, Melissa Shadoin, Samuel Pirruccello, MD, Shantaram S. Joshi, PhD

Blood (2015) 126 (23): 4135.

https://doi.org/10.1182/blood.V126.23.4135.4135

Published: 2015

Journal Articles

Absence of Caveloin-1 Leads to Delayed Development of Chronic Lymphocytic Leukemia in Eµ-TCL1 Mouse Model

Ashima Shukla, BS, Christine E Cutucache, PhD, Karan Rai, BS, Siddharth Rai, BS, Rene Opavsky, PhD, Patrick Swanson, PhD, Shantaram S Joshi, PhD

Blood (2014) 124 (21): 2196.

https://doi.org/10.1182/blood.V124.21.2196.2196

Published: 2014

Journal Articles

The Role Of PRDM1 and Its Interacting Proteins In The Pathogenesis Of Chronic Lymphocytic Leukemia

Ashima Shukla, BS, Nagendra K Chaturvedi, PhD, Shantaram S Joshi, PhD, Philip Bierman, MD, Adam Cornish, Sanjit Pandey, M.S., Chittibabu Guda, Ph.D

Blood (2013) 122 (21): 2865.

https://doi.org/10.1182/blood.V122.21.2865.2865

Published: 2013

Journal Articles

A role for IRF4 in the development of CLL

Vipul Shukla, Shibin Ma, Richard R. Hardy, Shantaram S. Joshi, Runqing Lu

Blood (2013) 122 (16): 2848–2855.

https://doi.org/10.1182/blood-2013-03-492769

Published: 2013

Journal Articles

Stromal Tumor Microenvironment in CLL: Regulation of Leukemic Progression

Nagendra K Chaturvedi, PhD, Adam K Ahrens, BA, Ashima Shukla, BS, Christine E Gilling, BS, Amit K. Mittal, PhD, DVM, MS, Philip Bierman, MD, Dennis D Weisenburger, MD, Runqing Lu, PhD, Shantaram S Joshi, PhD

Blood (2012) 120 (21): 1781.

https://doi.org/10.1182/blood.V120.21.1781.1781

Published: 2012

Journal Articles

Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Targeting NF-κB and mTOR Signaling Pathways in Vitro and in Vivo

Nagendra K Chaturvedi, PhD, Rajkumar Rajule, PhD, Shukla Ashima, BS, Prakash Radhakrishnan, PhD, Amarnath Natarajan, PhD, Julie M Vose, MD, MBA, Shantaram S Joshi, PhD

Blood (2012) 120 (21): 63.

https://doi.org/10.1182/blood.V120.21.63.63

Published: 2012

Journal Articles

A Role for Interferon Regulatory Factor 4 in the Development of CLL

Vipul Shukla, Shibin Ma, Megan Uehling, Shantaram S Joshi, PhD, Runqing Lu, PhD

Blood (2012) 120 (21): 714.

https://doi.org/10.1182/blood.V120.21.714.714

Published: 2012

Journal Articles

Heat-Shock Protein Signature Is Associated with Refractory Chronic Lymphocytic Leukemia Cells From Different In Vivo Microenvironments,

Payal Gupta, Amit K. Mittal, PhD, DVM, MS, Dennis D Weisenburger, MD, Philip Bierman, MD, Shantaram S Joshi, PhD

Blood (2011) 118 (21): 3866.

https://doi.org/10.1182/blood.V118.21.3866.3866

Published: 2011

Journal Articles

The Aggressive Molecular Signature of Peripheral Blood Chronic Lymphocytic Leukemia (CLL) Cells From Patients with Bulky Lymphadenopathy Closely Resembles That of CLL Cells From Lymph Nodes,

Amit K. Mittal, PhD, DVM, MS, Javeed Iqbal, PhD, Christine E Gilling, BS, Margaret Moragues, RN, R. Gregory Bociek, MD, Patricia Aoun, MD, Dennis D Weisenburger, MD, Shantaram S Joshi, PhD

Blood (2011) 118 (21): 3868.

https://doi.org/10.1182/blood.V118.21.3868.3868

Published: 2011

Journal Articles

Clinical Heterogeneity of CLL: Role for Immune Dysregulation Mediated by the Lymph Node Microenvironment.

Amit K Mittal, DVM, MS, Christine E Gilling, BS, Javeed Iqbal, Ph.D., R. Gregory Bociek, MD, Patricia Aoun, MD, Philip Bierman, MD, Shantaram S Joshi, PhD

Blood (2009) 114 (22): 1243.

https://doi.org/10.1182/blood.V114.22.1243.1243

Published: 2009

Journal Articles

Development of Vaccine-Based Immunotherapy for Murine Large B-Cell Lymphoma

Gayathri J. Kollessery, MS, Tara M. Nordgren, BS, Amit K. Mittal, DVM, MS, Ganapati V. Hegde, PhD, Sam D. Sanderson, PhD, Shantaram S. Joshi, PhD

Blood (2008) 112 (11): 2619.

https://doi.org/10.1182/blood.V112.11.2619.2619

Published: 2008

Journal Articles

Regulation of Chronic Lymphocytic Leukemia Cell Proliferation by CTLA4.

Amit K. Mittal, MVSc, DVM, Rae A. Rohlfsen, Avadhut D. Joshi, PhD, Ganapati V. Hegde, PhD, R. Gregory Bociek, MD, Shantaram S. Joshi, PhD

Blood (2007) 110 (11): 1140.

https://doi.org/10.1182/blood.V110.11.1140.1140

Published: 2007

Journal Articles

Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy.

Shantaram S. Joshi, PhD, Corey M. Munger, Ph.D., Ganapati V. Hegde, Ph.D., Dennis D. Weisenburger, M.D., Julie M. Vose, M.D.

Blood (2007) 110 (11): 2760.

https://doi.org/10.1182/blood.V110.11.2760.2760

Published: 2007

Journal Articles

GLI1 Transcription Factor: A Potential Therapeutic Target in B-CLL.

Ganapati V. Hegde, Katie J. Peterson, Katy Emanuel, Amit K. Mittal, Robert G. Bociek, Dennis D. Weisenburger, Shantaram S. Joshi

Blood (2007) 110 (11): 3100.

https://doi.org/10.1182/blood.V110.11.3100.3100

Published: 2007

Journal Articles

Sonic Hedgehog Signaling in Mantle Cell Lymphoma.

Ganapati V. Hegde, PhD, Katy Emanuel, Avadhut D. Joshi, Corey M. Munger, Dennis D. Weisenburger, M.D., Julie M. Vose, M.D., Shantaram S. Joshi, Ph.D.

Blood (2006) 108 (11): 2046.

https://doi.org/10.1182/blood.V108.11.2046.2046

Published: 2006

Journal Articles

Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression.

Avadhut D. Joshi, B.Pharm, John D. Dickinson, PhD, James C. Lynch, PhD, Philip J. Bierman, MD, Gregory R. Bociek, MD, Marcel P. Devetten, MD, James O. Armitage, MD, Shantaram S. Joshi, PhD

Blood (2005) 106 (11): 2103.

https://doi.org/10.1182/blood.V106.11.2103.2103

Published: 2005

Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD

Blood (2005) 106 (11): 3671.

https://doi.org/10.1182/blood.V106.11.3671.3671

Published: 2005

Journal Articles

Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion.

John D. Dickinson, BA, Avadhut Joshi, BS, Jamie Gilmore, BS, Philip J. Bierman, MD, Sanger Warren, PhD, Shantaram S. Joshi, PhD

Blood (2004) 104 (11): 971.

https://doi.org/10.1182/blood.V104.11.971.971

Published: 2004

NARROW

CLL Cells within the Proliferation Centers of the Patient Lymph Nodes Are Enriched for Notch Signaling, Thus NOTCH a Viable Target for CLL Therapy

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL

Mirna-21 Targets Sprouty2 to Activate SYK Mediated BCR and MAPK-Erk Signaling in Chronic Lymphocytic Leukemia

Absence of Caveloin-1 Leads to Delayed Development of Chronic Lymphocytic Leukemia in Eµ-TCL1 Mouse Model

The Role Of PRDM1 and Its Interacting Proteins In The Pathogenesis Of Chronic Lymphocytic Leukemia

A role for IRF4 in the development of CLL

Stromal Tumor Microenvironment in CLL: Regulation of Leukemic Progression

Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Targeting NF-κB and mTOR Signaling Pathways in Vitro and in Vivo

A Role for Interferon Regulatory Factor 4 in the Development of CLL

Heat-Shock Protein Signature Is Associated with Refractory Chronic Lymphocytic Leukemia Cells From Different In Vivo Microenvironments,

The Aggressive Molecular Signature of Peripheral Blood Chronic Lymphocytic Leukemia (CLL) Cells From Patients with Bulky Lymphadenopathy Closely Resembles That of CLL Cells From Lymph Nodes,

Clinical Heterogeneity of CLL: Role for Immune Dysregulation Mediated by the Lymph Node Microenvironment.

Development of Vaccine-Based Immunotherapy for Murine Large B-Cell Lymphoma

Regulation of Chronic Lymphocytic Leukemia Cell Proliferation by CTLA4.

Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy.

GLI1 Transcription Factor: A Potential Therapeutic Target in B-CLL.

Sonic Hedgehog Signaling in Mantle Cell Lymphoma.

Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression.

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only